PDSB - 6.14 Pre-market now at 6.70/6.78 PDS Biotechnology Announces Publication Supporting Novel Mechanisms of Action of its Proprietary Versamune® Platform in Cancer Immunotherapy https://www.tradescores.com/StockReport/pdsb